These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 26111667)

  • 21. U-shaped association between serum uric acid concentration and mortality in hypertrophic cardiomyopathy patients.
    Wang Z; Xu Y; Liao H; Chen X; He S
    Ups J Med Sci; 2020 Feb; 125(1):44-51. PubMed ID: 32013714
    [No Abstract]   [Full Text] [Related]  

  • 22. Prediction of cardiac death in patients with hypertrophic cardiomyopathy using plasma adipokine levels.
    Akita K; Hasegawa K; Fifer MA; Tower-Rader A; Jung J; Maurer MS; Reilly MP; Shimada YJ
    Nutr Metab Cardiovasc Dis; 2024 Jun; 34(6):1352-1360. PubMed ID: 38403486
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic value of red blood cell distribution width for mortality in patients with hypertrophic cardiomyopathy.
    Wang Z; Chen X; He S
    Clin Biochem; 2021 Oct; 96():19-25. PubMed ID: 34245695
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Elevated serum uric acid is an independent predictor for cardiovascular events in patients with severe coronary artery stenosis: subanalysis of the Japanese Coronary Artery Disease (JCAD) Study.
    Okura T; Higaki J; Kurata M; Irita J; Miyoshi K; Yamazaki T; Hayashi D; Kohro T; Nagai R;
    Circ J; 2009 May; 73(5):885-91. PubMed ID: 19336924
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cardiovascular magnetic resonance characteristics in children with hypertrophic cardiomyopathy.
    Chaowu Y; Shihua Z; Jian L; Li L; Wei F
    Circ Heart Fail; 2013 Sep; 6(5):1013-20. PubMed ID: 23873474
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Uric acid is an independent predictor of cardiovascular events in post-menopausal women.
    Sciacqua A; Perticone M; Tassone EJ; Cimellaro A; Miceli S; Maio R; Sesti G; Perticone F
    Int J Cardiol; 2015 Oct; 197():271-5. PubMed ID: 26142972
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic value of uric acid in patients with Type 2 diabetes mellitus and coronary artery disease.
    Ndrepepa G; Braun S; King L; Cassese S; Tada T; Fusaro M; Hadamitzky M; Haase HU; Schömig A; Kastrati A
    Clin Sci (Lond); 2013 Feb; 124(4):259-68. PubMed ID: 22974091
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic significance of serum uric acid in outpatients with chronic heart failure is complex and related to body mass index: data from the IN-CHF Registry.
    Baldasseroni S; Urso R; Maggioni AP; Orso F; Fabbri G; Marchionni N; Tavazzi L;
    Nutr Metab Cardiovasc Dis; 2012 May; 22(5):442-8. PubMed ID: 21193292
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gender differences in the association between serum uric acid and prognosis in patients with acute coronary syndrome.
    Kawabe M; Sato A; Hoshi T; Sakai S; Hiraya D; Watabe H; Kakefuda Y; Ishibashi M; Abe D; Takeyasu N; Aonuma K
    J Cardiol; 2016 Feb; 67(2):170-6. PubMed ID: 26228000
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serum uric acid and risk of occupational disability: findings from a cohort study of male construction workers in Germany.
    Claessen H; Brenner H; Drath C; Arndt V
    Arthritis Care Res (Hoboken); 2010 Sep; 62(9):1278-86. PubMed ID: 20506207
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic value of uric acid in patients with ST-elevated myocardial infarction undergoing primary coronary intervention.
    Kaya MG; Uyarel H; Akpek M; Kalay N; Ergelen M; Ayhan E; Isik T; Cicek G; Elcik D; Sahin O; Cosgun SM; Oguzhan A; Eren M; Gibson CM
    Am J Cardiol; 2012 Feb; 109(4):486-91. PubMed ID: 22100027
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Left atrial volume index: a predictor of adverse outcome in patients with hypertrophic cardiomyopathy.
    Yang WI; Shim CY; Kim YJ; Kim SA; Rhee SJ; Choi EY; Choi D; Jang Y; Chung N; Cho SY; Ha JW
    J Am Soc Echocardiogr; 2009 Dec; 22(12):1338-43. PubMed ID: 19879733
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The independent association between serum uric acid and graft outcomes after kidney transplantation.
    Haririan A; Nogueira JM; Zandi-Nejad K; Aiyer R; Hurley H; Cooper M; Klassen DK; Weir MR
    Transplantation; 2010 Mar; 89(5):573-9. PubMed ID: 19997058
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Are atherosclerotic risk factors associated with a poor prognosis in patients with hyperuricemic acute heart failure? The evaluation of the causal dependence of acute heart failure and hyperuricemia.
    Okazaki H; Shirakabe A; Kobayashi N; Hata N; Shinada T; Matsushita M; Yamamoto Y; Shibata Y; Shibuya J; Shiomura R; Nishigoori S; Asai K; Shimizu W
    Heart Vessels; 2017 Apr; 32(4):436-445. PubMed ID: 27672076
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Malondialdehyde and Uric Acid as Predictors of Adverse Outcome in Patients with Chronic Heart Failure.
    Romuk E; Wojciechowska C; Jacheć W; Zemła-Woszek A; Momot A; Buczkowska M; Rozentryt P
    Oxid Med Cell Longev; 2019; 2019():9246138. PubMed ID: 31687090
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Usefulness of combining serum uric acid and C-reactive protein for risk stratification of patients with coronary artery disease (Bezafibrate Infarction Prevention [BIP] study).
    Brodov Y; Behar S; Goldenberg I; Boyko V; Chouraqui P
    Am J Cardiol; 2009 Jul; 104(2):194-8. PubMed ID: 19576345
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Malignant effects of multiple rare variants in sarcomere genes on the prognosis of patients with hypertrophic cardiomyopathy.
    Wang J; Wang Y; Zou Y; Sun K; Wang Z; Ding H; Yuan J; Wei W; Hou Q; Wang H; Liu X; Zhang H; Ji Y; Zhou X; Sharma RK; Wang D; Ahmad F; Hui R; Song L
    Eur J Heart Fail; 2014 Sep; 16(9):950-7. PubMed ID: 25132132
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Asymptomatic hyperuricemia is not an independent risk factor for cardiovascular events or overall mortality in the general population of the Busselton Health Study.
    Nossent J; Raymond W; Divitini M; Knuiman M
    BMC Cardiovasc Disord; 2016 Dec; 16(1):256. PubMed ID: 27978810
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The long-term survival and the risks and benefits of implantable cardioverter defibrillators in patients with hypertrophic cardiomyopathy.
    O'Mahony C; Lambiase PD; Quarta G; Cardona M; Calcagnino M; Tsovolas K; Al-Shaikh S; Rahman SM; Arnous S; Jones S; McKenna W; Elliott P
    Heart; 2012 Jan; 98(2):116-25. PubMed ID: 21757459
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Uric Acid as prognostic marker in advanced nonischemic dilated cardiomyopathy: comparison with N-terminal pro B-type natriuretic peptide level.
    Kim H; Shin HW; Son J; Yoon HJ; Park HS; Cho YK; Han CD; Nam CW; Hur SH; Kim YN; Kim KB
    Congest Heart Fail; 2010; 16(4):153-8. PubMed ID: 20662867
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.